Lonza, a global manufacturing partner to the pharma, biotech and nutrition industries, is expanding its cell and gene therapies (CGT) process and analytical development laboratories at its locations in Houston (U.S.) and Geleen (NL).   The expansions further strengthen Lonza’s global process development service offering by adding capabilities and capacity to its existing laboratories. Alongside its rapidly growing team of CGT process development experts, the expansions support the company’s ab...